# Preeclampsia: Warning Signs, Screening and Aspirin Prevention

> A calm, OB-reviewed guide to recognizing preeclampsia symptoms, understanding ACOG/SMFM risk-factor screening, starting low-dose aspirin at the right time, and monitoring blood pressure at home.

*Published 2026-06-25 · By Priya Nair, MD*

The short answer
Preeclampsia is new-onset high blood pressure after 20 weeks of pregnancy, affecting 2–8% of pregnancies. Knowing the warning signs, understanding your risk factors, and — if you qualify — starting 81 mg of aspirin before 16 weeks can reduce your risk by about 24%. Home monitoring with a pregnancy-validated upper-arm cuff adds another safety layer.

Preeclampsia is one of those conditions that can feel abstract until it isn't. It affects somewhere between 2% and 8% of pregnancies worldwide, and in the United States it accounts for roughly 17.6% of maternal deaths. Yet research consistently shows that approximately 60% of those deaths are preventable — often through earlier recognition, systematic risk-factor screening, and a low-cost daily aspirin started at the right moment. That combination of serious risk and real prevention is exactly why this topic deserves a clear, unhurried explanation.

This guide covers what preeclampsia is, which symptoms should prompt an immediate call to your provider, how ACOG and SMFM screen for risk, the evidence behind low-dose aspirin prophylaxis, nutritional factors that emerging research is starting to clarify, and how to choose a home blood pressure monitor that is actually validated for use in pregnancy.

*A note before we begin: This article provides general health information grounded in current ACOG, SMFM, and USPSTF guidance. It is not a substitute for personalized medical advice. Please talk with your OB, midwife, or maternal-fetal medicine specialist about your individual risk and care plan.*

## What are the warning signs of preeclampsia — and when should I call my provider immediately?

Preeclampsia is defined as **new-onset blood pressure of 140/90 mmHg or higher after 20 weeks of gestation**, typically accompanied by proteinuria (protein in the urine) or evidence of end-organ dysfunction such as elevated liver enzymes, low platelets, or kidney impairment. The reason the 20-week threshold matters is that high blood pressure earlier in pregnancy usually reflects chronic hypertension, a different condition with a different management path.

What makes preeclampsia genuinely tricky is that it can progress without dramatic symptoms — which is why every prenatal visit includes a blood pressure check. Still, there are symptoms that should prompt you to call your provider the same day, and symptoms that are medical emergencies requiring you to go to labor and delivery or an emergency department right away.

**Call your provider today if you notice any of these:**

  - A new headache that is not relieved by acetaminophen (Tylenol)

  - Visual disturbances — blurred vision, seeing spots, or flashing lights

  - Right upper quadrant or epigastric (upper-middle belly) pain, especially with nausea

  - Sudden, significant swelling of the face, hands, or feet — beyond the normal ankle puffiness many pregnant women experience in the evening

  - Shortness of breath or a feeling of chest tightness

**Go to the hospital immediately — do not wait — if your blood pressure reads 160/110 mmHg or higher.** This is classified as severe-range hypertension and is a medical emergency. Severe-range blood pressure requires urgent antihypertensive treatment, typically with labetalol, nifedipine, or hydralazine, to reduce the risk of stroke, seizure, and placental complications. If you have a home blood pressure monitor, take a second reading after sitting quietly for five minutes before acting on any single number — but if the second reading is also 160/110 or higher, head in immediately.

It bears repeating: preeclampsia can worsen rapidly and sometimes without prominent symptoms. Routine blood pressure measurement at every prenatal visit is the foundational screening tool endorsed by [ACOG and the U.S. Preventive Services Task Force](https://www.ncbi.nlm.nih.gov/books/NBK570611/) precisely because of this. Keeping every scheduled appointment is not optional when it comes to this condition.

## How does my provider screen me for preeclampsia risk — and who should take low-dose aspirin?

ACOG and SMFM use a risk-factor framework, not a single blood or urine test, to identify who is most likely to benefit from aspirin prophylaxis. Risk factors are divided into high-risk and moderate-risk categories.

**High-risk factors** — each one individually sufficient to warrant daily aspirin — include:

  - A personal history of preeclampsia in a prior pregnancy

  - Multifetal gestation (twins, triplets, or more)

  - Chronic kidney disease

  - Autoimmune conditions: systemic lupus erythematosus or antiphospholipid syndrome

  - Pre-existing type 1 or type 2 diabetes

  - Chronic hypertension

**Moderate-risk factors** — where having more than one qualifies you for aspirin — include:

  - First pregnancy (nulliparity)

  - Maternal age 35 or older

  - BMI above 30 kg/m²

  - Family history of preeclampsia (first-degree relative)

  - IVF conception

  - Lower socioeconomic status

A [2026 SMFM special statement](https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pmf2.70212) updated the checklist to include 16 distinct risk factors spanning obstetric history, medical history, family history, and examination findings — the most comprehensive SMFM update to date. Under the current joint ACOG-USPSTF guidance, aspirin is now formally recommended for roughly one-third of all pregnancies and considered or recommended for as many as 85% when every risk tier is applied.

The standard prophylactic dose is **81 mg of aspirin taken daily**, initiated between 12 and 28 weeks of gestation — but the evidence strongly favors starting **before 16 weeks**. When aspirin is initiated in that earlier window, the USPSTF found it reduces preeclampsia risk by approximately 24%. Starting after 16 weeks still provides some benefit, but substantially less. Aspirin is continued through delivery; stopping it early without consulting your provider is not recommended.

Quick reference: Low-dose aspirin protocol
**Dose:** 81 mg daily  |  **Start:** Before 16 weeks (between 12–28 weeks)  |  **Stop:** At delivery  |  **Timing:** Evening may be modestly more effective  |  **Gate:** Only take if your provider confirms you qualify — aspirin is not appropriate for every pregnancy.

## What nutritional and lifestyle factors influence preeclampsia risk?

While aspirin is the most evidence-backed prophylactic intervention, a growing body of research points to modifiable nutritional factors that may meaningfully support vascular and placental health.

**Vitamin D** has attracted the most rigorous research attention. A 2024 systematic review and meta-analysis of 33 randomized controlled trials involving more than 10,600 participants, published in *BMC Pregnancy and Childbirth*, found that vitamin D supplementation [reduced preeclampsia risk by approximately 45%](https://pmc.ncbi.nlm.nih.gov/articles/PMC11668112/). A 2025 meta-analysis of five additional RCTs confirmed a statistically significant reduction (relative risk 0.61; 95% CI 0.50–0.75; p < 0.001), with the protective effect largest in women with baseline serum 25-OH vitamin D below 20 ng/mL. The proposed mechanisms include vitamin D's role in improving vascular endothelial function, reducing oxidative stress, and supporting immune tolerance of the placenta. From a functional-medicine standpoint, aiming for serum 25-OH vitamin D of 40–60 ng/mL early in pregnancy — through a combination of sensible sun exposure and supplementation — is a reasonable, low-risk preventive step worth discussing with your provider.

**Magnesium, calcium, and zinc** have also shown meaningful preventive effects. An RCT found that a combined multimineral-vitamin D supplement containing 800 mg calcium, 200 mg magnesium, 8 mg zinc, and 400 IU vitamin D3 daily significantly lowered preeclampsia incidence relative to placebo.

**Environmental chemical exposures** are an underappreciated modifiable risk factor. A 2025 systematic review found that endocrine-disrupting chemicals — including bisphenol A (BPA) and phthalates found in food packaging, personal-care products, and plastics — alter placental microRNA signaling in ways consistent with preeclampsia pathophysiology. Urinary BPA concentrations at 10 weeks of gestation were associated with a 1.53-fold increase in preeclampsia risk in that analysis. Practical minimization steps include reducing processed-food packaging, filtering drinking water, and avoiding synthetic-fragrance personal-care products that contain phthalates.

To be clear about what the evidence does and does not support: nutritional optimization is a reasonable complement to standard clinical care, not a replacement for it. Aspirin prophylaxis, blood pressure monitoring, and prompt clinical response remain the non-negotiable pillars of preeclampsia prevention and management.

## How do I monitor blood pressure at home — and which devices are actually validated for pregnancy?

Home blood pressure monitoring has become an important part of preeclampsia risk management for pregnant women, particularly those with identified risk factors. But here is something many people do not realize: most consumer blood pressure monitors on the market have not been independently validated for use in pregnancy, and accuracy matters significantly when you are tracking a condition as serious as this.

**The single best resource for choosing a monitor is the [STRIDE BP international registry's pregnancy-specific list](https://www.stridebp.org/pregnancy-pdf/)**, which is free and regularly updated. Upper-arm cuff devices are strongly preferred over wrist or finger monitors, which tend to be less accurate in pregnancy. Validated options documented in the clinical literature include:

  - **iHealth Track** — featured in the Preeclampsia Foundation's Cuff Kit program, which bundles the monitor with evidence-based education materials for at-risk patients

  - **Omron M3 Comfort** and **Omron Evolv** — both passed the Universal Standard Protocol validation for pregnancy and preeclampsia populations

  - **Microlife** upper-arm automated monitors — validated for pregnancy use

  - **Withings BPM Connect** — Bluetooth connectivity and color-coded feedback for easy data sharing with your provider via smartphone

  - **Prevounce Pylo 900-LTE** — FDA-cleared as a pregnancy-validated remote monitoring device specifically designed for detecting gestational hypertension and preeclampsia in telehealth programs

For the most accurate readings: sit quietly for five minutes before measuring, use the device at the same time each day, keep your arm at heart level, and measure twice with a one-minute interval between readings. Share your log at every prenatal visit. If a reading is above 140/90, sit quietly and retake it; if the second reading is also elevated, call your provider. If a reading is 160/110 or higher on retesting, go to the hospital.

Preeclampsia is a condition where preparation, information, and consistent monitoring genuinely change outcomes. Knowing the warning signs, understanding whether you qualify for aspirin, and tracking blood pressure with the right tool — these are the things within your reach. The rest is your care team's job, and the research is clear that when everyone plays their role, the great majority of preeclampsia-related tragedies are preventable.

## Sources

1. [Preeclampsia — Warning Signs, Clinical Presentation and Management](https://www.ncbi.nlm.nih.gov/books/NBK570611/)
2. [Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality](https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/12/low-dose-aspirin-use-for-the-prevention-of-preeclampsia-and-related-morbidity-and-mortality)
3. [Updated checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin](https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pmf2.70212)
4. [The Cuff Kit — Pregnancy Blood Pressure Monitoring Program](https://www.preeclampsia.org/the-cuff-project)
5. [Validated Devices for Blood Pressure Measurement in Pregnancy and Preeclampsia](https://www.stridebp.org/pregnancy-pdf/)
6. [Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta-analysis](https://pmc.ncbi.nlm.nih.gov/articles/PMC11668112/)
7. [Endocrine-Disrupting Chemicals and the Effects of Distorted Epigenetics on Preeclampsia: A Systematic Review](https://pmc.ncbi.nlm.nih.gov/articles/PMC11987890/)
8. [Changes in Low-Dose Aspirin Use After Updated Guidance](https://journals.lww.com/ogopen/fulltext/2025/04000/changes_in_low_dose_aspirin_use_after_updated.2.aspx)

---
Source: https://natalnew.com/prenatal-care/preeclampsia-warning-signs-prevention
Index: https://natalnew.com/llms.txt · Full text: https://natalnew.com/llms-full.txt